You are here:HomeLive TVVideosNewsOrbit: No Respite In Sight

Orbit: No respite in sight


Rising debt levels and sagging cash flows marked Orbit Corp's Q3 earnings. The pace of execution and launches is expected to pick up in next few quarters.

Social Sharing


  • BSE
  • NSE
Company Price (Rs.) CHG %
BIOCON 500.50 10.10%
ASHOKLEY 24.25 5.21%
YESBANK 437.10 4.85%
BANKINDIA 229.60 4.55%
More from Top Gainers »
Don't Miss


Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2014. All rights reserved.